Literature DB >> 2910675

Clostridium difficile colitis secondary to intravenous vancomycin.

J R Hecht1, E J Olinger.   

Abstract

Nearly every known antibiotic has been implicated as a cause of Clostridium difficile colitis. We report the first case resulting from monotherapy with intravenous vancomycin. The patient was on chronic hemodialysis and was treated with intravenous vancomycin for presumed cervical osteomyelitis. After 29 days of therapy he developed abdominal pain and diarrhea and his stool was found to contain both C. difficile and cytotoxin. The patient responded with symptomatic and microbiological recovery to withdrawal of the drug and treatment with oral metronidazole. The prolonged elevation of serum vancomycin levels in patients with renal failure may predispose them to the development of C. difficile colitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910675     DOI: 10.1007/BF01536172

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Some laboratory and clinical experiences with a new antibiotic, vancomycin.

Authors:  J E GERACI; F R HEILMAN; D R NICHOLS; G T ROSS; W E WELLMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-10-17

2.  Pharmacokinetics of vancomycin in anuria.

Authors:  B A Cunha; R Quintiliani; J M Deglin; M W Izard; C H Nightingale
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

3.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors.

Authors:  G P Young; N Bayley; P Ward; D J St John; M I McDonald
Journal:  Med J Aust       Date:  1986-03-17       Impact factor: 7.738

5.  Clostridium difficile: epidemiology and clinical features.

Authors:  T J Marrie; M Furlong; R S Faulkner; J Sidorov; E V Haldane; E A Kerr
Journal:  Can J Surg       Date:  1982-07       Impact factor: 2.089

6.  Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis.

Authors:  R Fekety; K H Kim; D H Batts; R A Browne; M A Cudmore; J Silva; R Toshniwal; K H Wilson
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

Review 7.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun

8.  Bacterial interference between Clostridium difficile and normal fecal flora.

Authors:  R D Rolfe; S Helebian; S M Finegold
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.

Authors:  T A Bowden; A R Mansberger; L E Lykins
Journal:  Am Surg       Date:  1981-04       Impact factor: 0.688

  9 in total
  6 in total

1.  Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

Authors:  J A Kink; J A Williams
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Authors:  Brian T Bateman; Jeremy A Rassen; Sebastian Schneeweiss; Katsiaryna Bykov; Jessica Myers Franklin; Joshua J Gagne; Jennifer M Polinski; Jun Liu; Alexander Kulik; Michael A Fischer; Niteesh K Choudhry
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-28       Impact factor: 5.209

3.  In vitro and in vivo activities of nitazoxanide against Clostridium difficile.

Authors:  C S McVay; R D Rolfe
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Clostridium difficile colitis.

Authors:  Judith L Trudel
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 5.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

6.  Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine.

Authors:  Abdallah Damin Abukhalil; Liana AbuKhdeir; Malak Hamed; Ni'meh Al Shami; Hani A Naseef; Banan M Aiesh; Ali Sabateen
Journal:  Infect Drug Resist       Date:  2021-11-09       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.